Lewis, Mark D <br/><br/>
A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Mar 2004 
 - 1068-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2003-030652  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Body Height--genetics<br/>Child<br/>Crystallography, X-Ray<br/>Genetic Testing<br/>Growth Disorders--genetics<br/>Human Growth Hormone--chemistry<br/>Humans<br/>MAP Kinase Signaling System--physiology<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Point Mutation<br/>Promoter Regions, Genetic--genetics<br/>Protein Structure, Tertiary